Home » Newsletters » BioWorld

BioWorld

March 30, 2000

View Archived Issues

Helix Raises C$22.75M To Fund Development Of Three Projects

Other News To Note

Cytogen Plans $50.9M Stock Offering To Boost PSMA Work

Long-Fought Amgen-TKT Case Back In Federal Court In Boston

Cellegy Enters Pivotal Phase III Trial On Low-Testosterone Gel

Cell Therapeutics Files NDA For Drug Treating Relapsed Leukemia

Putting Methylation, Epigenesis And Imprinting Of Genes Into Picture of Future Medical Practice

NeoTherapeutics Starts Phase II/III Trial Of Neotrofin In Alzheimer's

Researchers Complete Two-Thirds Of Base Pairs In Genome Project

Management Challenges For Biotech In The 21st Century